We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.5%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$752M
AUM Growth
+$49.1M
(+7%)
Cap. Flow
-$1.92M
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
23.82%
Holding
526
New
12
Increased
2
Reduced
7
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHCT
Community Healthcare Trust
CHCT
|
+$489K |
| 2 |
NSA
National Storage Affiliates Trust
NSA
|
+$458K |
| 3 |
Biogen
BIIB
|
+$454K |
| 4 |
CareTrust REIT
CTRE
|
+$353K |
| 5 |
VMEO
Vimeo
VMEO
|
+$289K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CUB
Cubic Corporation
CUB
|
+$969K |
| 2 |
AEGN
Aegion Corp
AEGN
|
+$690K |
| 3 |
GLUU
Glu Mobile Inc.
GLUU
|
+$574K |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$515K |
| 5 |
SYNC
Synacor, Inc.
SYNC
|
+$482K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.28% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.87% |
| 4 | Industrials | 12.46% |
| 5 | Communication Services | 9.2% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q2 2021 Portfolio in Review
As of Q2 2021, NJ State Employees Deferred Compensation Plan held 526 positions worth $752M, up 7% from $703M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 4.2%. NJ State Employees Deferred Compensation Plan opened 12 new positions and exited 10, leaving the 526-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- NJ State Employees Deferred Compensation Plan's largest Q2 2021 buy was Community Healthcare Trust: 10,000 shares worth $475K.
- NJ State Employees Deferred Compensation Plan added most to Biogen in Q2 2021, an estimated $454K increase.
- NJ State Employees Deferred Compensation Plan's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $515K.
- NJ State Employees Deferred Compensation Plan fully exited Cubic Corporation in Q2 2021, selling an estimated $969K.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 24% of its $752M portfolio in Q2 2021.
- NJ State Employees Deferred Compensation Plan opened 12 new positions and closed 10 in Q2 2021.
- NJ State Employees Deferred Compensation Plan's portfolio value rose 7% quarter-over-quarter to $752M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2021, filed 23 Jul 2021.